Oncolys BioPharma Inc. (4588) Dividends
Market cap
¥70.4B
P/E ratio
Develops viral therapies for cancer treatment and severe infections, with lead candidate OBP-301 targeting solid tumors like esophageal cancer.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of Oncolys BioPharma Inc., the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>We recognize returning profits to shareholders as an important management priority. We determine our dividend policy by considering each period's business results, while also taking into account the need to strengthen our management foundation and build up internal reserves for aggressive business expansion. Our articles of incorporation provide for annual year-end dividends as the standard practice, with interim dividends also permitted when distributing surplus earnings.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2026/02/06) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2026/02/06) | 0 | 0 | 0 | - |
| Forecast(2025/02/07) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2025/02/07) | 0 | 0 | 0 | - |
| Forecast(2024/02/09) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2024/02/09) | 0 | 0 | 0 | - |
| Forecast(2023/02/10) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2023/02/10) | 0 | 0 | 0 | - |
| Forecast(2022/02/10) | 0 | 0 | 0 | - | |
| FY2021 | Actual(2022/02/10) | 0 | 0 | 0 | - |
| Forecast(2021/02/12) | 0 | 0 | 0 | - | |
| FY2020 | Actual(2021/02/12) | 0 | 0 | 0 | - |
| Forecast(2020/11/06) | 0 | 0 | 0 | - | |
| FY2019 | Actual(2020/11/06) | 0 | 0 | 0 | - |